Disease Progression
Showing 1 - 25 of >10,000
Peri-Implant Disease Progression: A Prospective Study
Recruiting
- Peri-Implantitis
- Bleeding of Subgingival Space
- Clinical measurements
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh School of Dental Medicine
Sep 5, 2023
Huntington Disease Trial (radiotracer injection)
Not yet recruiting
- Huntington Disease
- radiotracer injection
- (no location specified)
Mar 29, 2023
Interleukins in Periodontal Disease Progression
Recruiting
- Periodontitis
- Gingivitis
- Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
-
Assiut, Asyut, EgyptDepartment of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Not yet recruiting
- Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
- (no location specified)
Aug 23, 2023
Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Observation
- (no location specified)
Oct 12, 2023
Natural History of Coronary Atherosclerosis
Not yet recruiting
- Coronary Artery Disease Progression
- +3 more
- (no location specified)
Sep 13, 2023
Alzheimer, Magnetic Resonance Spectroscopy, Ultra High Field 7T Trial (MRI follow-up)
Not yet recruiting
- Alzheimer Disease
- +4 more
- MRI follow-up
- (no location specified)
Jun 30, 2023
Interstitial Lung Disease
Active, not recruiting
- Interstitial Lung Disease
-
Rome, Roma, ItalyFondazione Policlinico Agostino Gemelli IRCCS
Feb 27, 2023
Disease Progression and Outcome of Aortic Stenosis in Humans
Not yet recruiting
- Aortic Stenosis
- +5 more
-
Bonn, Germany
- +2 more
May 5, 2023
Quantifying Disease Progression in LBSL
Recruiting
- LBSL
- Leukoencephalopathies
-
Amsterdam-Zuidoost, Noord-Holland, NetherlandsAmsterdam UMC
Feb 28, 2023
Facioscapulohumeral Muscular Dystrophy Type 2 Trial in France, Italy, Spain (Validation of new COMs for FSHD2 patients)
Recruiting
- Facioscapulohumeral Muscular Dystrophy Type 2
- Validation of new COMs for FSHD2 patients
-
Nice, Alpes M, France
- +5 more
Oct 6, 2023
Knee Osteoarthritis, Cartilage Degeneration, Malalignment, Bone Trial in Bologna (valgus producing medial opening wedge high
Active, not recruiting
- Knee Osteoarthritis
- +2 more
- valgus producing medial opening wedge high tibial osteotomy
-
Bologna, ItalyStefano Zaffagnini
May 16, 2023
Parkinson's Disease Trial (rTMS real stimulation stage1, rTMS shame stimulation stage1, rTMS real stimulation stage 2)
Not yet recruiting
- Parkinson's Disease
- rTMS real stimulation stage1
- +2 more
- (no location specified)
Aug 15, 2023
COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)
Not yet recruiting
- COVID 19 Disease
- +4 more
- Tafenoquine Oral Tablet
- Placebo
- (no location specified)
Jul 13, 2023
Extracellular Vesicles for HD
Not yet recruiting
- Huntington Disease
- (no location specified)
Oct 17, 2023
Describing DME, Their Patient Journey and Disease Progression
Not yet recruiting
- Diabetic Macular Edema
- (no location specified)
Jul 21, 2023
Proteomics and Genomics Combined With CT to Predict CVD
Recruiting
- Coronary Artery Disease Progression
-
Amsterdam, NetherlandsAmsterdam UMC, location AMC
Mar 23, 2023
NSCLC Trial in Shanghai (Toripalimab, Cryoablation)
Not yet recruiting
- Non-small Cell Lung Cancer
- Toripalimab
- Cryoablation
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 7, 2023
First Progression of Glioblastoma Trial (Lomustine, Reirradiation)
Not yet recruiting
- First Progression of Glioblastoma
- Lomustine
- Reirradiation
- (no location specified)
Jun 6, 2023
Disease Characteristics of IR-CAD: a Case-control Study
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Protocol-defined Examinations
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 17, 2023
Survival Analysis in Children and Adults Adrenocortical Cancer
Active, not recruiting
- Adrenocortical Carcinoma
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jan 20, 2023
Prostatic Tumor, Adenocarcinoma, Tumor Recurrence Trial in Rennes, Pointe-à-Pitre (Standard care)
Recruiting
- Prostatic Neoplasm
- +3 more
- Standard care
-
Rennes, Ille-et-Vilaine, France
- +1 more
Sep 14, 2023
Metastatic Prostate Cancer Trial in Salt Lake City (dietary supplement, other, behavioral)
Not yet recruiting
- Metastatic Prostate Cancer
- creatine monohydrate
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Oct 30, 2023
Disease Progression in Pelizaeus-Merzbacher Disease
Recruiting
- Pelizaeus-Merzbacher Disease
-
Parkville, Australia
- +4 more
Dec 13, 2022
Lewy Body Disease Trial in Jacksonville, Rochester (18F-Flortaucipir)
Enrolling by invitation
- Lewy Body Disease
-
Jacksonville, Florida
- +1 more
Dec 1, 2022